Elayne Penebre

Elayne Penebre has a strong background in the field of biology, with extensive experience in various roles. Elayne is currently the VP of Biology at Dunad Therapeutics since December 2022. Prior to that, they worked at Faze Medicines as the VP of Biology from January 2021 to November 2022.

Before joining Faze Medicines, Elayne held multiple positions at Epizyme starting in 2010. Elayne served as a Senior Director from August 2019 to December 2020, a Director from February 2018 to August 2019, a Principal Scientist from September 2014 to February 2018, a Senior Scientist from May 2012 to September 2014, and a Scientist from May 2010 to May 2012.

Earlier in their career, Elayne worked as a Post-Doctoral Fellow at Children's Hospital Boston from January 2005 to July 2009. Elayne also served as a PhD Graduate Student at The Hospital for Sick Children from 1999 to 2004.

Elayne Penebre's work experience demonstrates their expertise and progression in the field of biology, making their a valuable asset to any organization.

Elayne Penebre completed their education from 1995 to 2004 at the University of Toronto. During this time, they obtained an Hon.BSc and a PhD degree in Medical and Molecular Genetics.